DYRK1A and familial pancreatic carcinoma: In addition to neurological disorders, DYRK1A dysregulation has been linked to cancer (especially lung and pancreatic cancers), glioblastoma, melanoma, leukemia, diabetes, and heart diseases [78,110,111].